20-12-2023 01:50 PM | Source: Sushil Finance
Neutral Kilitch Drugs (India) Ltd for Target Rs. 393 - Sushil Finance
We have coverage on Kilitch Drugs (India) Ltd. with a BUY rating on stock. Since our report, the stock has posted a high of Rs.381 today.
With the recent run-up in the share price (27% return), we are now changing our rating on the stock to Neutral.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report & Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer
Latest News
Over 100 million Indians can get gigabit connectivit...
Airtel, Google Cloud join hands to deploy GenAI solu...
Sensex closes 111 points up after intra-day volatility
Evening Roundup : A Daily Report on Bullion Energy &...
FIIs stood as net sellers in equities as per May 13 ...
Daily market commentary: Nifty recovered from lower ...
Post-market comment by Deven Mehata ,Research Analys...
Daily Market Analysis : The week kicked off with mar...
Mahindra & Mahindra and Ministry of Skill Developmen...
Quote On National Technology Day 2024 By Mr. Su Piow...